Is AOD-9604 FDA Approved? What the Evidence Actually Shows

AOD-9604 is not FDA approved. The FDA has not approved AOD-9604 for weight loss, fat loss, body composition, or any other human use in the United States, and there is no legal prescription or over-the-counter AOD-9604 product. What you can buy online is an unapproved research chemical that has never cleared the agency's safety and effectiveness review.

AOD-9604's FDA Status in Plain Terms

For anyone who has typed is aod-9604 fda-approved into a search bar, the answer is a flat no, and no recent regulatory action has changed that. AOD-9604 sits in an unusual spot: it is not an approved drug, and it is not a legal dietary supplement ingredient either.

Here is how US regulators actually treat it:

• No approved drug application. No company holds an approved New Drug Application or biologics license for AOD-9604, so there is no FDA-reviewed labeling, dose, or indication.
• Not eligible for 503A compounding. The FDA placed AOD-9604 in Category 2 of its evaluation of bulk drug substances for compounding — the category for substances that may pose significant safety risks.
• Not a legal dietary supplement. AOD-9604 is not a recognized dietary ingredient, so it cannot legally be sold as a supplement in the US.
• Banned in sport. The World Anti-Doping Agency lists AOD-9604 under S0, meaning it is prohibited at all times for competing athletes.

What AOD-9604 Actually Is

AOD-9604 is a synthetic fragment of human growth hormone — specifically the section running from amino acid 176 to 191. Researchers designed it to mimic HGH's fat-metabolizing activity while avoiding the hormone's effects on growth, blood sugar, and IGF-1.

An Australian company, Metabolic Pharmaceuticals, developed it in the 1990s as an anti-obesity drug candidate. It never reached market approval anywhere, and the obesity development program was discontinued. Since then it has been studied in small trials related to joint and cartilage health, but that research is far too limited to support an approval.

What Human Trials Found — and Didn't Find

Phase II trials of AOD-9604 in adults with obesity reported only modest changes in weight and fat mass. The results were not strong enough to justify a Phase III program, and development for weight loss stopped. There is still no large, long-term randomized trial showing that AOD-9604 produces meaningful, durable fat loss in people.

That evidence gap matters. FDA approval requires proof of effectiveness plus a safety database large enough to characterize common and serious risks. AOD-9604 has neither.

How AOD-9604 Compares to FDA-Approved Options

Comparing aod 9604 vs tesamorelin is a useful exercise, because it shows exactly what "approved" means in practice. Peptide forums often treat the two as interchangeable fat-loss tools. They are not.

Product	FDA status	Approved use	How it's given	Evidence base
AOD-9604	Not approved	None	Injection (gray market)	Small Phase II trials only
Tesamorelin (Egrifta)	Approved	Excess abdominal fat in HIV-associated lipodystrophy	Daily injection	Large randomized trials
Semaglutide (Wegovy)	Approved	Chronic weight management	Weekly injection	Large randomized trials
Tirzepatide (Zepbound)	Approved	Chronic weight management	Weekly injection	Large randomized trials

Tesamorelin is approved for one narrow indication, not for general weight loss. Semaglutide and tirzepatide are approved for chronic weight management in eligible patients, and both require a prescription and medical supervision.

Why "FDA Approved" Claims Keep Spreading

Peptide vendors rarely say "FDA approved" outright, because that would be false advertising. Instead they use phrases that sound similar to a casual reader.

• "Manufactured in an FDA-registered facility." Facility registration is a paperwork step, not a product approval.
• "For research use only." This label shifts legal responsibility to the buyer and is not a safety claim.
• "Pharmaceutical grade" or "99% pure." These are marketing terms with no regulatory definition for unapproved peptides.

Independent testing of gray-market peptides has repeatedly found products that are mislabeled, underdosed, or contaminated with other peptides and bacterial byproducts. A certificate of analysis from the seller is not independent verification.

Dosage and Reconstitution: No Approved Reference Exists

Because AOD-9604 is not approved, there is no official aod 9604 dosage and no FDA-reviewed label to consult. Numbers that circulate online — often 250 to 500 mcg per day injected subcutaneously — come from forums and seller pages, not from controlled trials. No clinical study has established a safe or effective human dose.

The same problem applies to aod 9604 reconstitution. Users mix lyophilized powder with bacteriostatic water using instructions written by other users. Mistakes in volume, storage, or sterility can lead to injection-site infections or dosing errors, and an unapproved peptide carries no guarantee about what is actually inside the vial.

Benefits, Side Effects, and Real Risks

Any honest discussion of aod 9604 benefits and side effects has to start with the limits of the data. Small, short trials cannot rule out rare or long-term harms, and nobody has published safety data on years of continuous use.

• Reported in trials: mild injection-site reactions, headache, and occasional gastrointestinal upset.
• Unknown: long-term effects on immune signaling, hormone pathways, and cartilage or joint tissue.
• Gray-market risks: contamination, incorrect dosing, and reactions to unidentified compounds.
• Legal risks: importing or selling unapproved peptides can run afoul of federal law, and the FDA has issued warning letters to companies that market them.

Anyone considering AOD-9604 should talk with a licensed healthcare professional first. People who want evidence-based fat loss have FDA-approved, prescriber-supervised options with known dosing and monitoring.

The Bottom Line

AOD-9604 is not FDA approved for any human use. The FDA has flagged AOD-9604 as a bulk substance with potential safety concerns, which keeps it out of 503A compounding. Human trials never produced results strong enough to support approval, and no approved dosing or safety label exists. Buying AOD-9604 online means purchasing an unverified research chemical with unknown purity, unknown risks, and no regulatory oversight.

COMMON QUESTIONS

Frequently Asked Questions

Is AOD-9604 FDA approved?

No. AOD-9604 has never received FDA approval for weight loss or any other human use, and no AOD-9604 product is legally marketed as a drug or a dietary supplement in the United States. The FDA has also placed AOD-9604 in Category 2 of its 503A bulk drug substances review, the category reserved for substances that may pose significant safety risks.

Can you legally buy AOD-9604 in the United States?

Not as a drug or a supplement. Products labeled AOD-9604 are typically sold as research chemicals with "not for human consumption" disclaimers, which is a legal workaround rather than an approval. Importing unapproved peptides for personal use can violate federal law, and purity claims from sellers are not independently verified.

Does AOD-9604 actually work for weight loss?

Human trials reported only modest changes in weight and fat mass, and the obesity development program was discontinued. There is no large, long-term trial showing meaningful, lasting fat loss from AOD-9604. FDA-approved prescription options such as semaglutide and tirzepatide have far stronger evidence and should be discussed with a clinician.